List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone (Radicava)
Table 4. Key Players of Other
Table 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2019-2024)
Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2025-2030)
Table 11. Amyotrophic Lateral Sclerosis Therapeutics Market Trends
Table 12. Amyotrophic Lateral Sclerosis Therapeutics Market Drivers
Table 13. Amyotrophic Lateral Sclerosis Therapeutics Market Challenges
Table 14. Amyotrophic Lateral Sclerosis Therapeutics Market Restraints
Table 15. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2023)
Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
Table 22. Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Mitsubishi Tanabe Pharma Company Detail
Table 48. Mitsubishi Tanabe Pharma Business Overview
Table 49. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 50. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Mitsubishi Tanabe Pharma Recent Development
Table 52. Sanofi Company Detail
Table 53. Sanofi Business Overview
Table 54. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product
Table 55. Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Sanofi Recent Development
Table 57. Mylan Pharma Company Detail
Table 58. Mylan Pharma Business Overview
Table 59. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 60. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Mylan Pharma Recent Development
Table 62. Apotex Company Detail
Table 63. Apotex Business Overview
Table 64. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product
Table 65. Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Apotex Recent Development
Table 67. Glemark Generics Company Detail
Table 68. Glemark Generics Business Overview
Table 69. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product
Table 70. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Glemark Generics Recent Development
Table 72. Covis Pharma Company Detail
Table 73. Covis Pharma Business Overview
Table 74. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 75. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Covis Pharma Recent Development
Table 77. Sun Pharma Company Detail
Table 78. Sun Pharma Business Overview
Table 79. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 80. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Sun Pharma Recent Development
Table 82. Lunan Pharma Company Detail
Table 83. Lunan Pharma Business Overview
Table 84. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 85. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Lunan Pharma Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Riluzole Features
Figure 4. Edaravone (Radicava) Features
Figure 5. Other Features
Figure 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Drugs Store Case Studies
Figure 10. Other Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
Figure 12. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players in 2023
Figure 16. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2023
Figure 18. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2019-2030)
Figure 32. China Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 47. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 48. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 49. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 50. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 51. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 52. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 53. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed